Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma
Madhusmita Behera(National Institutes of Health), Gabriel Sica(Emory University), Fadlo R. Khuri(American University of Beirut Medical Center), Conor Steuer(Emory University), Suresh S. Ramalingam(Emory University), Sungjin Kim(Cedars-Sinai Medical Center), Rathi N. Pillai(Emory University), Anthony A. Gal(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center)
Cited by 94
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k